Abstract
Despite many attempts, there is currently no approved vaccine to prevent Staphylococcus aureus infections. Preclinical vaccination models have failed to predict vaccine efficacy in humans as S . aureus exposure in humans imprints an immune response that is lacking in naive animals. In this issue of the JCI , Tsai and colleagues identify the cytokine IL-10 as the driver of humoral imprinting by S . aureus . Upon vaccination, S . aureus –experienced animals produced copious levels of IL-10, resulting in the hyper-α2,3 sialylation of antibodies, which interfered with the phagocytic-promoting properties of the vaccine-elicited anti– S . aureus antibodies. These findings correlate with the observation that hyperproduction of IL-10 in humans also induces hyper-α2,3 sialylation of antibodies and provide a possible mechanism for previous vaccine failures.

This publication has 23 references indexed in Scilit: